Lincoln Pharmaceuticals Limited (NSE:LINCOLN)

Lincoln Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	57.47	50.52	69.34	138.41	122.31
Short-Term Investments	-	1.18	116.57	113.82	-	-
Trading Asset Securities	-	1,389	913.26	968.06	806.65	342.16
Cash & Short-Term Investments	1,974	1,448	1,080	1,151	945.06	464.47
Cash Growth	15.59%	34.01%	-6.16%	21.81%	103.47%	97.16%
Accounts Receivable	-	1,618	1,363	1,159	1,133	1,013
Other Receivables	-	0.64	1.35	3.4	2.06	-
Receivables	-	2,011	1,604	1,490	1,333	1,178
Inventory	-	771.68	700.28	727.42	466.13	473.96
Prepaid Expenses	-	16.25	19.36	3.73	11.37	10.89
Other Current Assets	-	220.48	268.29	156.19	331.8	353.07
Total Current Assets	-	4,467	3,672	3,528	3,088	2,480
Property, Plant & Equipment	-	1,825	1,569	1,476	1,119	1,132
Long-Term Investments	-	0.04	0.03	0.03	1.04	0.86
Goodwill	-	-	-	-	-	92.26
Other Intangible Assets	-	3.26	2.95	3.83	3.98	3.69
Other Long-Term Assets	-	47.63	33.74	65.15	59.76	37.39
Total Assets	-	7,003	5,874	5,344	4,524	3,894
Accounts Payable	-	724.4	508.67	716.67	570.66	512.43
Accrued Expenses	-	90.06	82.92	70.14	58.49	31.86
Short-Term Debt	-	10.67	19.97	20.44	-	38.33
Current Portion of Long-Term Debt	-	-	-	-	3.75	3.92
Current Income Taxes Payable	-	0.71	8.82	42.77	31.59	9.37
Other Current Liabilities	-	96.93	101.08	54.85	93.91	59.93
Total Current Liabilities	-	922.77	721.45	904.86	758.4	655.83
Long-Term Debt	-	-	-	-	1.45	8.49
Long-Term Unearned Revenue	-	36.25	47.21	45.39	42.92	40.52
Long-Term Deferred Tax Liabilities	-	114.56	79.41	64.55	56.91	54.33
Total Liabilities	-	1,075	849.46	1,015	859.67	759.17
Common Stock	-	200.3	200.3	200.3	200.3	200
Additional Paid-In Capital	-	646.17	646.17	646.17	646.17	646.17
Retained Earnings	-	5,182	4,279	3,580	2,916	2,285
Comprehensive Income & Other	-	-100.06	-100.67	-97.7	-99	0.22
Total Common Equity	6,393	5,928	5,025	4,329	3,664	3,131
Minority Interest	-	-	-	-	-	3.82
Shareholders' Equity	6,393	5,928	5,025	4,329	3,664	3,135
Total Liabilities & Equity	-	7,003	5,874	5,344	4,524	3,894
Total Debt	13.55	10.67	19.97	20.44	5.2	50.74
Net Cash (Debt)	1,961	1,437	1,060	1,131	939.86	413.73
Net Cash Growth	15.40%	35.53%	-6.22%	20.31%	127.17%	-
Net Cash Per Share	97.87	71.75	52.94	56.46	46.92	20.69
Filing Date Shares Outstanding	20.03	20.03	20.03	20.03	20	20
Total Common Shares Outstanding	20.03	20.03	20.03	20.03	20	20
Working Capital	-	3,545	2,951	2,624	2,329	1,824
Book Value Per Share	319.26	295.98	250.86	216.12	183.20	156.54
Tangible Book Value	6,389	5,925	5,022	4,325	3,660	3,035
Tangible Book Value Per Share	319.10	295.82	250.72	215.93	183.00	151.75
Land	-	200.24	187.36	186.32	172.57	154.99
Buildings	-	602.21	580.66	478.61	357.92	358.79
Machinery	-	1,548	1,192	1,031	875.31	849.42
Construction In Progress	-	34.83	67.14	160.54	16.86	0.4

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.